105 results
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
indications, geographic expansions, and enhanced patient experience through integrated healthcare technologies. In our hematology and specialty care … in the subcutaneous space between the skin and the muscle. Because it is delivered subcutaneously, HYQVIA can be administered by a healthcare professional
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
patients, healthcare professionals, employees, clients such as suppliers and vendors, creditors and local communities in order to strengthen long … therapeutic areas. He has also served in several key positions at global pharmaceutical and healthcare companies in the U.S. and Europe. He has deep insights
6-K
TAK
Takeda Pharmaceutical Co
30 Oct 23
Current report (foreign)
6:02am
and GAMMAGARD S/D) through pursuit of new indications, geographic expansions, and enhanced patient experience through integrated healthcare
6-K
TAK
Takeda Pharmaceutical Co
1 Aug 23
Current report (foreign)
6:10am
) through pursuit of new indications, geographic expansions, and enhanced patient experience through integrated healthcare technologies. In our hematology
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
12 Jul 23
Current report (foreign)
6:07am
, healthcare professionals, employees, clients such as suppliers and vendors, creditors and local communities in order to strengthen long- term … at global pharmaceutical and healthcare companies in the U.S. and Europe. He has deep insights gained from his extensive experience in the management
6-K
EX-99.1
d6qhg8oi
6 Jul 23
Current report (foreign)
6:18am
6-K
EX-99.1
d48cjh0
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
j0prur1
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
hyl2ks5y
30 May 23
Current report (foreign)
6:11am
6-K
xngk4fx
8 Dec 22
Current report (foreign)
6:46am
6-K
EX-99.1
ifg90j3y
30 Nov 22
Current report (foreign)
6:28am
6-K
lzgzepj
4 Nov 22
Current report (foreign)
6:01am
6-K
v2w6x
14 Oct 22
Current report (foreign)
7:36am
6-K
m8bm4m
4 Oct 22
Current report (foreign)
6:06am
6-K
gzemgj5u
4 Aug 22
Current report (foreign)
6:07am
6-K
b5x9osycmpzj9hnpfo
11 Jul 22
Current report (foreign)
6:05am
6-K
EX-99.1
1f4ma
31 May 22
Current report (foreign)
6:14am